Company news

In the workshop of Xiamen Wiz Biotech Co., Ltd, workers dressed in neat overalls sit in front of the operating table and methodically pack test reagents for COVID-19 antigen.

As of September 26, 267 cases of COVID-19 had been confirmed in Xiamen, of which 221 had been confirmed. During the epidemic, the local government has carried out multiple rounds of citywide epidemic screening, establishing a reliable barrier for epidemic prevention and control.

iamen Wiz Biotech Co., Ltd is located in Xiamen Biopharmaceutical Port. The company takes rapid diagnosis as its entry point and focuses on gastrointestinal and digestive fields. From research and development, registration and approval, to market access, sales network......

COVID-19 has become a "global epidemic", and all countries are in urgent need of COVID-19 testing reagents. In order to effectively support the international community in tackling the global epidemic crisis,

Our company's "Novel Coronavirus Antibody Screening and Shunt Prevention and Control rapid detection system" has been approved by Xiamen Science and Technology Bureau.

Xiamen Wiz Biotech Co., Ltd. was listed and traded on the New Third Board on February 5, 2017. The stock name is Wiz Biotech (stock code 839355).

The 2016 annual Awards & Dinner party was held in Xiamen Mingshi Jindian Seafood Hotel.

Xiamen WIZ Biotech Co., LTD., founded in July 2013, is a high-tech company engaged in the research and development, production and sales of rapid diagnostic reagents and instruments.

In 2015, Xiamen Wiz Biotech Co., Ltd obtained high-tech enterprise certificate after the relevant government departments strict assessment. Wiz Biotech will take this opportunity to continuously carry out technological innovation and improve the technical level of the enterprise.

Wiz Biotech has obtained ISO9001 and ISO13485 certificates in Jan 5th, 2016, which shows that our enterprise has a perfect quality management system.